Biotest AG
SWB:BIO3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
SWB:BIO3
|
DE |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
Packaging Corp of America
NYSE:PKG
|
US |
|
D
|
Datatec Ltd
JSE:DTC
|
ZA |
|
I
|
Imperial Oil Ltd
SWB:IMP
|
CA |
|
H
|
High Tide Inc
XBER:2LYA
|
CA |
|
W
|
Westpac Banking Corp
NZX:WBC
|
AU |
|
P
|
Poolbeg Pharma PLC
LSE:POLB
|
UK |
|
C
|
Charles Schwab Corp
BMV:SCHW
|
US |
|
A
|
AMN Healthcare Services Inc
SWB:HCQ
|
US |
|
A
|
Arcadis NV
F:HIJ2
|
NL |
|
Jabil Inc
NYSE:JBL
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
XBER:75C
|
CN |
|
Softronic AB
STO:SOF B
|
SE |
|
Y
|
Yue Yuen Industrial (Holdings) Ltd
XMUN:YUE1
|
HK |
|
Vidrala SA
F:VIR
|
ES |
|
J
|
JD.Com Inc
XBER:013C
|
CN |
|
S
|
Sigma Lithium Corp
NASDAQ:SGML
|
CA |
|
P
|
Procter & Gamble Co
XBER:PRG
|
US |
|
Asian Television Network International Ltd
OTC:AITVF
|
CA |
|
C
|
Ctp NV
PSE:CTPNV
|
NL |
|
B
|
Bidvest Group Ltd
JSE:BVT
|
ZA |
|
C
|
Ciena Corp
XMUN:CIE1
|
US |
Bankruptcy Probability
Biotest AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotest AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Biotest AG
XETRA:BIO
|
1.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotest AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotest AG has total debt of 639.8m EUR. This includes both short-term (0 EUR) and long-term (639.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
